Navigation

Investiment.io
Financial analysis platform

Bristol-Myers Squibb Company

BMY โ€ข NYSE

$63.33
โ–ผ0.10 (0.16%)โ€ข REGULAR

Bristol-Myers Squibb Company

$63.33
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ง

Cash Flow StatementBMY

Cash Flow Summary

Key cash flow metrics and liquidity indicators for BMY

๐Ÿ”„
Operating Cash Flow
$14,156,000
(in thousands)
๐Ÿ’ฐ
Free Cash Flow
$12,845,000
(in thousands)
๐Ÿ—๏ธ
Capital Expenditures
-$1,311,000
(in thousands)
๐Ÿ“ˆ
Net Change in Cash
-$129,000
(in thousands)

Cash Flow Analysis

Analyze operating, investing, and financing cash flows over time

Period:annual

Select Metrics to Compare (4 selected)

Net Operating Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$4.50B$9.00B$13.50B$18.00B-20%-10%0%+10%+20%
  • Net Operating Cash Flow
  • Net Operating Cash Flow YoY Growth

Free Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$4.00B$8.00B$12.00B$16.00B-22%-11%0%+11%+22%
  • Free Cash Flow
  • Free Cash Flow YoY Growth

Capital Expenditures Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-1.33B$-1.24B$-1.14B$-1.04B$-950.00M-15%-12%-9%-6%-3%
  • Capital Expenditures
  • Capital Expenditures YoY Growth

Net Change in Cash Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-5.00B$-2.50B$0.00K$2.50B$5.00B-750%-500%-250%0%+250%
  • Net Change in Cash
  • Net Change in Cash YoY Growth